MK0476, montelukast sodium / Duration of Treatment: 4 weeks

DRUG2 trials

Sponsors

Organon and Co

Conditions

Asthma

Phase 3

Study of an Approved Drug in Patients With Asthma (0476-289)(COMPLETED)

CompletedNCT00092144

Organon and CoAsthma

Start: 2004-02-26End: 2004-06-15Target: 500Updated: 2024-08-15

Phase 4

Montelukast Post-Marketing Comparative Study With Ketotifen (0476-379)

CompletedNCT00446056

Organon and CoAsthma

Start: 2003-09-25End: 2004-06-16Updated: 2024-08-15